Medications for Febrile Neutropenia

4 results

  • neulasta - pegfilgrastim

    (Pegfilgrastim)
    Amgen, Inc
    Neulasta reduces infection risk from febrile neutropenia in adults and pediatric patients with non-myeloid malignancies undergoing myelosuppressive chemotherapy. Also increases survival in patients acutely exposed to myelosuppressive radiation doses. Not indicated for stem cell transplantation progenitor cell mobilization.
    Medication Details
    Drug Interactions

  • neupogen - filgrastim injection, solution

    (Filgrastim)
    Amgen, Inc
    NEUPOGEN is a leukocyte growth factor used to reduce infection risk and neutropenia in cancer patients on chemotherapy or bone marrow transplant, treat AML-related neutropenia, mobilize stem cells for collection, manage severe chronic neutropenia, and improve survival after myelosuppressive radiation exposure.
    Medication Details
    Drug Interactions

  • nyvepria - pegfilgrastim - apgf injection, solution

    (Pegfilgrastim-Apgf)
    Pfizer Laboratories Div Pfizer Inc
    Nyvepria reduces infection risk (febrile neutropenia) in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. Not indicated for peripheral blood progenitor cell mobilization for stem cell transplantation.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • rolvedon - eflapegrastim - xnst injection, solution

    (Eflapegrastim-Xnst)
    Spectrum Pharmaceuticals, Inc.
    Rolvedon reduces the risk of febrile neutropenia in adults with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. Not indicated for peripheral blood progenitor cell mobilization for stem cell transplantation.
    Medication Details
    Drug Interactions